Vision
To build an Indian precision-diagnostics ecosystem where advanced cancer and infectious-disease testing can reach patients across Tier 1, Tier 2 and Tier 3 communities through affordable, decentralized and point-of-care-ready access.
About us
A MedTech company translating Indian innovation into accessible precision diagnostics.
Genesis Next Gen Biomaterials is developing protected platform programs for cancer and infectious disease diagnostics, with a focus on affordability, domestic manufacturing, decentralized access and disciplined communication.
Our Purpose: Innovation that expands access to meaningful diagnostics
Mission
To translate domestic precision-diagnostics innovation into locally manufacturable, amplification-free liquid-biopsy platform programs that support ultra-sensitive diagnostics at affordable cost through decentralized laboratory pathways.
Values
Purpose
Develop diagnostics around meaningful patient and public-health needs.
Scientific responsibility
Communicate accurately, protect sensitive platform information and avoid unsupported claims.
Accessibility
Design with affordability, geography and laboratory access in mind.
Collaboration
Combine scientific, clinical, engineering and commercial perspectives.
Quality
Build disciplined development practices into research and product translation.
Indian innovation
Advance domestic capability while participating in global scientific collaboration.